RESUMEN
AIM OF THE STUDY: The basic uses of C-reactive protein (CRP) and procalcitonin (PCT) in clinical practice are in the diagnosis and follow-up of infectious disease. The fact that CRP already achieves high levels in cases with lung cancer, however, limits its diagnostic specificity. Procalcitonin may be an important marker in the differential diagnosis of lung cancer patients who have fever and high CRP levels. Our objective in this study was to determine the levels of CRP and PCT in patients with newly diagnosed non-infectious non-small cell lung cancer (NSCLC) and to relate these results to patient and disease characteristics. MATERIAL AND METHODS: Serum CRP and PCT levels were measured in 79 histopathologically proven NSCLC patients and 20 healthy controls. Results were compared with demographic and clinical variables in patients with NSCLC. RESULTS: Serum CRP concentrations were significantly higher in NSCLC patients compared to the control group [38.30 (7.79-185) mg/dl vs. 7.79 (3.36-26.10) mg/dl; p < 0.001]. There was no significant difference between the two groups in PCT levels (p > 0.05). A mild, positive correlation was found between CRP level and tumor diameter. When comparing CRP levels in the lung cancer patients grouped according to age, sex, smoking status, clinical TNM staging and performance status (PS), the only significant difference found was that for PS score. CONCLUSIONS: High serum CRP levels in non-infectious NSCLC patients are mainly related to PS status and weakly to tumor size. Adding serum PCT measurement may contribute to exclusion of infections in patients with NSCLC.
RESUMEN
Bleomycin causes pulmonary fibrosis by increasing free oxygen radicals. Cigarette smoke is a strong oxidant which adversely affects pulmonary tissue. We evaluated the effects of cigarette smoke administered with intratracheal bleomycin on pulmonary tissue. We studied 3 groups of rats (n=10): one group received intratracheal saline and served as a control; one received intratracheal bleomycin (IT) (0.5 U/100 g body weight, single dose on the first day), and one group received intratracheal bleomycin (single dose on first day) and tobacco smoke (two times per day) (IT-S). After 4 weeks, the levels of malondialdehyde (MDA) and nitric oxide (NO) and the activities of superoxide dismutase (SOD) and xanthine oxidase (XO) were assayed in the homogenate of the lung tissue samples. The severity of interstitial fibrosis was assessed using the grading system described by Ashcroft. There was more intensive fibrosis in the IT and IT-S than in the control samples (P<0.001). The levels of MDA, NO and activity of XO were significantly increased (P<0.001, <0.002 and <0.002, respectively), and SOD activity (P<0.001) was significantly decreased in the IT group when compared to these values in the control group. The concentration of NO was significantly decreased (P<0.002), and SOD activity was significantly increased (P<0.05) in the lung tissue samples of the IT-S group. Theoretically, the combination of cigarette smoke and bleomycin may have a synergistic effect on oxidative lung injury. In conclusion, we showed that inhalation of cigarette smoke provides protection against oxidative stress in the lung tissue of rats with bleomycin-induced pulmonary fibrosis.
RESUMEN
Pleural effusion is a relatively infrequent finding in multiple myeloma (MM) and malign effusions due to myelomatous effusion is seen very rarely. In this article we reported a case with bilateral myelomatous effusion. Myelomatous etiology was detected by demonstrating gammopathy in pleural fluid protein electrophoresis and demonstrating abundant number of atypical plasma cells in pleural fluid cytology. Pleural fluids due to MM are usually seen in IgA type of MM's, IgG on the surface of CD-138 positive cell was demonstrated in flow cytometric study of the pleural fluid of the reported case. In conclusion we mentioned that a patient who does not have diagnosis of MM before may present with pleural involvement, the involvement may be bilateral and flow cytometry can be used in diagnosis.
Asunto(s)
Mieloma Múltiple/diagnóstico , Derrame Pleural/etiología , Anciano , Diagnóstico Diferencial , Humanos , Masculino , Mieloma Múltiple/complicaciones , Mieloma Múltiple/diagnóstico por imagen , Mieloma Múltiple/patología , Derrame Pleural/patología , Tomografía Computarizada por Rayos XRESUMEN
Sensitization to Alternaria and Cladosporium has been reported to be 3% to 30% in European countries. However, in Turkey, there is limited data about the prevalence of sensitization to these molds and the intensity of the two mold spores in Ankara atmosphere. This study was designed to evaluate the sensitization to Alternaria and Cladosporium in patients with respiratory allergy in Ankara and also the concentration of the two molds in Ankara atmosphere. Allergic rhinitis and asthma patients living in Ankara were included in the study. Demographic and diagnostic data of the patients were recorded. A skin prick test with extracts supplied by three different laboratories was used to evaluate the sensitization to Alternaria and Cladosporium. Mold spores were measured using a Burkard 7-day recording volumetric spore trap in Ankara atmosphere during a year. Overall sensitization to the two molds was found to be 14.8%, and isolated Alternaria or Cladosporiumsensitization was 3%. Considering the positive reaction to at least one of the three suppliers, the sensitization rate was 11.9% and 8.1% for Alternaria and Cladosporium, respectively. Cochran's Q homogenization test demonstrated that the positive and negative reaction were not homogeneous among three laboratories. The total number of mold spores in Ankara atmosphere was 429,264 spores/m3 of which 75.5% and 6% were constituted by Cladosporium and Alternaria, respectively. The prevalence of Cladosporium and Alternaria sensitization in respiratory allergy patients is quite similar to European countries; however, our data indicate that commercial mold extracts should be standardized to establish the real sensitization rates. Additionally, considering the great numbers of these mold spores in Ankara atmosphere, long-term follow-up studies are needed to evaluate the relationship between the mold load and sensitization patterns.
Asunto(s)
Alternaria/inmunología , Asma/etiología , Cladosporium/inmunología , Rinitis Alérgica Perenne/etiología , Rinitis Alérgica Estacional/etiología , Esporas Fúngicas/inmunología , Adolescente , Adulto , Niño , Recuento de Colonia Microbiana , Femenino , Humanos , Masculino , Persona de Mediana EdadRESUMEN
BACKGROUND: Intolerance to acetylsalicylic acid (ASA) and other nonsteroidal anti-inflammatory drugs (NSAIDs) is a crucial problem in clinical practice. There is, therefore, a need for safer NSAIDs in patients with analgesic intolerance. OBJECTIVE: To assess the safety of nimesulide, meloxicam, and rofecoxib, selective COX-2 inhibitors, in a group of ASA/NSAIDs-intolerant patients. METHOD: Tolerances to nimesulide, meloxicam, and rofecoxib were assessed by single-blind placebo-controlled oral challenges. One hundred twenty-seven subjects with history of adverse reaction to ASA/NSAIDs received oral challenges with nimesulide, 61 subjects were challenged with meloxicam, 51 subjects were challenged with rofecoxib, and 37 subjects were challenged with all three drugs. Placebos were given to all patients on the first day of the study. On the second day, one-fourth and three-fourths of the therapeutic doses of the active drugs (nimesulide 100 mg, meloxicam 7.5 mg, or rofecoxib 25 mg) were given at 60-minute intervals. There was at least a 3-day interval between challenge tests. Erythema, pruritus accompanied by erythema, urticaria/angioedema, rhinorrhea, nasal obstruction, sneezing, dyspnea, or cough associated with a decrease of at least 20% in the forced expiratory volume (FEV1) and hypotension were considered as positive reactions. RESULTS: Positive reactions to the nimesulide, meloxicam, and rofecoxib challenges were observed in 18/127 (14.3%), 5/61 (8.1%), and 1/51 (2.0%) patients, respectively. In each group of nine patients, there were two patients with asthma and four who developed skin type reactions and asthmatic reactions, respectively, to the nimesulide challenge. Among five patients who reacted to the meloxicam challenge, asthmatic type reactions were detected in two asthmatics. Only one urticarial type reaction was observed with rofecoxib challenge in one patient who presented with anaphylaxis to ASA/NSAIDs. All patients with asthma tolerated rofecoxib without any adverse effects. None of the patients reacted to the placebo. Among 37 patients challenged with all three drugs, 11 reacted to nimesulide, and one patient reacted only to meloxicam. Three patients reacted to more than one of the drugs tested, and one of them reacted to all drugs. CONCLUSION: This is the first placebo-controlled report comparing these three drugs. The results indicate that among these alternative drugs for ASA/NSAIDs-intolerant patients, rofecoxib seems to have the most favorable tolerability.
Asunto(s)
Inhibidores de la Ciclooxigenasa/efectos adversos , Hipersensibilidad a las Drogas/etiología , Lactonas/efectos adversos , Sulfonamidas/efectos adversos , Tiazinas/efectos adversos , Tiazoles/efectos adversos , Adolescente , Adulto , Anciano , Antiinflamatorios no Esteroideos/efectos adversos , Aspirina/efectos adversos , Asma/inducido químicamente , Femenino , Humanos , Pruebas Inmunológicas/métodos , Masculino , Meloxicam , Persona de Mediana Edad , Método Simple Ciego , Sulfonas , Resultado del Tratamiento , Urticaria/inducido químicamenteAsunto(s)
Albendazol/administración & dosificación , Equinococosis Pulmonar/diagnóstico , Equinococosis Pulmonar/tratamiento farmacológico , Enfermedades Pleurales/diagnóstico , Enfermedades Pleurales/tratamiento farmacológico , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Femenino , Estudios de Seguimiento , Humanos , Imagen por Resonancia Magnética , Persona de Mediana Edad , Índice de Severidad de la Enfermedad , Tomografía Computarizada por Rayos X , Resultado del Tratamiento , TurquíaRESUMEN
In this study, 80 cases with pleural effusion hospitalized at the departments of Chest Diseases and Internal Medicine in the Medical School of Selcuk University, and 30 healthy people as control group were studied. Regarding to the diagnosis, pleural fluids were classified into two groups as follows; transudates and exudates. Difference between the mean pleural pseudocholinesterase levels of transudates and exudates was statistically significant (p< 0.001). Similar significance was also obtained in the mean pleural fluid/serum pseudocholinesterase ratios of the groups (p< 0.001). In determination of exudative fluids both sensitivity and specificity of the pleural fluid pseudocholinesterase level was 100%. Sensitivity and specificity of the pleural fluid/serum pseudocholinesterase ratio were 90 and 87%, respectively. We have concluded that pleural pseudocholinesterase level and pleural fluid/serum pseudocholinesterase ratio can be used as a parameter with high diagnostic efficiency in discrimination of pleural effusions as exudates and transudates.
Asunto(s)
Butirilcolinesterasa/metabolismo , Derrame Pleural/diagnóstico , Derrame Pleural/metabolismo , Adulto , Biomarcadores/metabolismo , Butirilcolinesterasa/sangre , Estudios de Casos y Controles , Exudados y Transudados/metabolismo , Femenino , Humanos , Masculino , Persona de Mediana Edad , Derrame Pleural/sangre , Valor Predictivo de las Pruebas , Sensibilidad y EspecificidadRESUMEN
In this study, pleural fluid and serum lipid-bound sialic acid (LBSA) levels of 68 cases with pleural effusion hospitalised at the department of Chest Diseases in the Medical School of Selçuk University, and serum LBSA levels of 30 healthy individuals as control group were studied. Pleural effusions of 32 cases were due to malignancy of which considerably lung cancer. In the other 36 cases the causes were nonmalignant in origin. Levels of mean serum LBSA in malignant and benign groups were significantly higher than control group (p< 0.001). However, difference of the mean serum LBSA levels of malignant and benign groups was not statistically significant. We found the mean pleural fluid LBSA level of 23.34 mg/dL in malignant group and it was significantly higher than benign group (17.97 mg/dL) (p< 0.05). It was observed that there was no significant statistical difference between the pleural fluid to serum LBSA ratios of malignant and benign groups. In differential diagnosis of malignant pleural effusions, sensitivity and specificity of pleural fluid LBSA were 91%, and 51%, respectively. In conclusion, for the differentiation of malignant pleural effusions LBSA is not believed to be a reliable tumor marker since it may also increase in various chronic and inflammatory diseases. Despite of that, in cases with a suspicion of malignancy, the increased level of pleural fluid LBSA may be useful as a supportive parameter.
Asunto(s)
Biomarcadores de Tumor/sangre , Derrame Pleural Maligno/diagnóstico , Ácidos Siálicos/sangre , Estudios de Casos y Controles , Femenino , Humanos , Masculino , Persona de Mediana Edad , Derrame Pleural Maligno/sangre , Valor Predictivo de las Pruebas , Curva ROC , Sensibilidad y EspecificidadAsunto(s)
Aneurisma/complicaciones , Síndrome de Behçet/tratamiento farmacológico , Ciclofosfamida/uso terapéutico , Cardiopatías/complicaciones , Inmunosupresores/uso terapéutico , Arteria Pulmonar/diagnóstico por imagen , Trombosis/complicaciones , Adulto , Aneurisma/diagnóstico por imagen , Síndrome de Behçet/complicaciones , Colchicina/uso terapéutico , Diagnóstico Diferencial , Quimioterapia Combinada , Glucocorticoides/uso terapéutico , Cardiopatías/diagnóstico por imagen , Humanos , Masculino , Trombosis/diagnóstico por imagen , Tomografía Computarizada por Rayos X , UltrasonografíaRESUMEN
With regard to changes in life-style after the 1980s, the reflection of environmental factors on the evolution of allergic airway disease (AAD) has not yet been analyzed in Turkey. In this trial, we aimed to determine the factors related to AAD in Turkish subjects. Patients diagnosed as having asthma and/or rhinitis with positive skin prick tests (SPTs) were accepted as members of the "atopic group" (n = 235). Subjects demonstrated to have negative SPTs and no clinical evidence of any atopic disorder were accepted as members of the "nonatopic control group" (n = 84). Data obtained from a questionnaire applied cross-sectionally to the study groups were compared for risk factor analysis. According to the results of univariate analysis, nonatopic controls were found to have been born in villages more frequently than those in the atopic group (14.3% vs. 4.7%, p = 0.02). Atopic group members had lived in apartments during childhood more frequently than nonatopic controls (53.6% vs. 38%, p = 0.04). A topic group members, particularly the asthmatics, had lower sibship size (< or = 1 sibling) (41.3% vs. 16.7%, p = 0.0003) and nonatopic subjects had higher sibship size (> or = 3 siblings) (73.8% vs. 43.4%, p < 0.0001). The rate of maternal atopy was higher in the atopic group (24.7% vs. 9.5%, p = 0.02). Place of birth, sibship size, and atopic status of the mother, but not house type, were found to be significant in the multivariate analysis. As a conclusion, rural life-style seems to have a protective effect on the development of atopy in Turkey. On the contrary, factors directly or indirectly related to urban life-style during early childhood were found to be associated with the allergic airway diseases.
Asunto(s)
Hipersensibilidad/complicaciones , Enfermedades Respiratorias/etiología , Adulto , Estudios Transversales , Femenino , Humanos , Hipersensibilidad/diagnóstico , Estilo de Vida , Masculino , Análisis Multivariante , Factores de Riesgo , Población Rural , Pruebas Cutáneas , Turquía , Población UrbanaRESUMEN
The factors underlying analgesic intolerance (AI), particularly the role of ethnic characteristics, are readily not clear. In this trial, we aimed to assess the predictive features of AI in Turkish subjects. One hundred and ninety patients with AI were enrolled into the study conducted in our tertiary care clinic. The types of drug causing adverse reaction(s) and types of reaction(s) were recorded. The presence of atopy was assessed by skin prick tests. According to the results, the most frequently intolerated analgesic was acetyl salicylic acid (72.1%), followed by nonsteroidal anti-inflammatory drugs (68.4%) and paracetamol (15.8%). Urticaria/angioedema (52.6%) and asthmatic response (40.5%) were the most common reactions to analgesics. Compared with the general adult population of Turkey, the rate of atopy was found be higher in patients with AI and asthma (25% vs. 45%, p = 0.004) but comparable in patients with AI but no atopic disorder (25% vs. 29.2%, p> 0.05). In conclusion, subjects exhibiting intolerance to analgesics have particular features in our population; the presence of atopy in these subjects seems to be associated with the coexistent asthma rather than the drug allergy itself.